Laboratoire National de métrologie et d'Essais (LNE), ZA Trappes-Elancourt, 29 Rue Roger Hennequin, 78190, Trappes, France.
NanoMesureFrance, LNE, 1 rue Gaston Boissier Paris Cedex 15, Paris, 75724, France.
Drug Deliv Transl Res. 2024 Sep;14(9):2578-2588. doi: 10.1007/s13346-024-01646-2. Epub 2024 Jun 12.
The French National Metrology Institute (LNE) initiated a series of events to identify priorities for test methods and their harmonisation that directly address regulatory needs in Nanomedicine. One of these workshops entitled "The International Standardisation Roadmap for Nanomedicine" held in October 2023 (Paris, France) brought together key experts in the characterisation of nanomedicines and medical products containing nanomaterials, including the Joint Research Centre of the European Commission, SINTEF Industry and the metrology institutes of France, the UK, the USA and Canada, two flagship initiatives of the European Commission (PHOENIX and SAFE-n-MEDTECH Open Innovation Test Beds), representatives of a working party on mRNA vaccines at the European Directorate for the Quality of Medicines (EDQM) and members of international standardisation and pre-normative organisations (including CEN, ISO, ASTM, VAMAS). Two take-home message came out from the discussion. First, developing standard test methods and Reference Materials (RMs) for nanomedicines is a key priority for the European Commission and various stakeholders. Furthermore, there was a unanimous recognition of the need for a unified approach between standardisation committees, regulators and the nanomedicine community. At the USA, Canadian and European level, examples of success stories and of future initiative have been discussed. Future perspectives include the creation of a dedicated Working Group under CEN/TC 352 to consolidate efforts and develop a nanomedicine standardisation roadmap.
法国国家计量研究院(LNE)发起了一系列活动,以确定直接满足纳米医学监管需求的测试方法及其协调的优先事项。这些活动之一是题为“纳米医学国际标准化路线图”的研讨会,于 2023 年 10 月在法国巴黎举行,汇集了纳米药物和含纳米材料的医疗产品特性方面的主要专家,包括欧盟委员会联合研究中心、挪威科技工业研究院和法国、英国、美国和加拿大的计量学研究所、欧盟委员会的两个旗舰倡议(凤凰计划和 SAFE-n-MEDTECH 开放创新测试平台)、欧洲药品质量管理局(EDQM)mRNA 疫苗工作组的代表以及国际标准化和预规范组织(包括 CEN、ISO、ASTM、VAMAS)的成员。讨论得出了两个重要结论。首先,为纳米药物开发标准测试方法和参考物质(RMs)是欧盟委员会和各利益相关方的一个关键优先事项。此外,与会者一致认识到标准化委员会、监管机构和纳米医学界之间需要采取统一的方法。在美国、加拿大和欧洲,已经讨论了成功案例和未来倡议的例子。未来的展望包括在 CEN/TC 352 下创建一个专门的工作组,以巩固努力并制定纳米医学标准化路线图。